DaVita Clinical Research Deutschland GmbH
- Address
- Bismarckstrasse 101, Stadtmitte, 40210 Düsseldorf, Germany
DaVita Clinical Research Deutschland GmbH - Renal and Cardiovascular Research Excellence
DaVita Clinical Research Deutschland GmbH is a specialized clinical research center dedicated to advancing treatment options for patients with kidney disease and related cardiovascular conditions. With extensive expertise in dialysis technologies and renal therapeutics, the center conducts pivotal trials that address critical unmet needs in nephrology and lipid management.
- Advanced glomerular diseases including IgA nephropathy and focal segmental glomerulosclerosis (FSGS) with novel therapeutic interventions
- End-stage renal disease management and dialysis optimization, including hemodialysis vascular access complications and peritoneal dialysis solutions
- Cardiovascular-renal interface research focusing on hyperlipoproteinemia(a) and lipoprotein apheresis
The center demonstrates particular strength in evaluating innovative dual-pathway modulators like sparsentan for proteinuric kidney diseases, conducting long-term nephroprotection studies that assess both efficacy and safety outcomes. Their research portfolio includes pioneering work in glucose-sparing peritoneal dialysis solutions, prevention of arteriovenous graft thrombosis in hemodialysis patients, and novel approaches to managing severe lipid disorders through pharmacological alternatives to apheresis therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Iperboreal Pharma S.r.l.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Travere Therapeutics Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in DaVita Clinical Research Deutschland GmbH
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Sparsentan in Patients with Immunoglobulin A Nephropathy: A Randomized, Double-Blind, Active-Controlled Study | Travere Therapeutics Inc. | Phase III | Not Recruiting | Feb 2019 | — |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Irbesartan | 2 | Unknown | 2018-10-15 | 2019-02-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.